EU funds research into causes and new therapies for multiple sclerosis
Multiple sclerosis (MS), an inflammatory disease of the central nervous system, affects more than 1 million people in Europe and an estimated 2.8 million worldwide. MS is characterized by an inflammation-related loss and damage of the myelin layer in the brain and spinal cord, which insulates the nerves – potentially leading to serious consequences such as paralysis or severe visual impairment. The cause of this damage is not known. Viral infections, particularly with the Epstein-Barr virus, have been suspected for years. However, ...
Read the release
















